Medical/Pharmaceuticals

Tergus Lauded by Frost & Sullivan for Its Full-spectrum CRO Services for Therapeutics in Dermatology

With scalable, advanced resource and technology capabilities, Tergus presents pharma companies with exceptional CRO services for all their drug discovery and development requirements SANTA CLARA, Calif., March 8, 2021 /PRNewswire/ -- Based on its recent analysis of the North American contract re...

2021-03-08 22:00 241

Wugen Announces Exclusive Partnership Agreement With Alpha Biopharma in Asia For Cell Therapies to Treat Cancer

ST. LOUIS, March 8, 2021 /PRNewswire/ -- Wugen Inc., a clinical-stage biotechnology company developing novel universal natural killer (NK) and T-cell therapies for the treatment of cancer, today announced that it has entered into an exclusive license and collaboration agreement withShanghai-based...

2021-03-08 22:00 210

Ortho's New COVID-19 Total and IgG Antibody Tests Receive CE Mark for Semi-Quantitative Results

- Ortho's new VITROS® Anti-SARS-CoV-2 Total 2 Antibody assay and VITROS® Anti-SARS-CoV-2 IgG 2 Antibody assay receive CE Mark - Both tests can aid in identifying individuals with an adaptive immune response (acquired naturally or through vaccination) to SARS-CoV-2 - These new anti-SARS-CoV-2 ant...

2021-03-08 21:00 280

Changzhou National High-Tech Zone to build 70 new production and service facilities this year

CHANGZHOU, China, March 8, 2021 /PRNewswire/ -- On the morning of February 27th , Changzhou National High-Tech Zone held the groundbreaking ceremony for Phase II of Intersurgical Medical Device (Changzhou) Co., Ltd.'s plant. The ceremony is the first of similar events for zone's 70 planned product...

2021-03-08 17:11 453

Elekta wins lawsuit against Livian GmbH

STOCKHOLM, March 8, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that theLondon Court of International Arbitration (LCIA) has awarded in favor of Elekta in a dispute with Livian GmbH (formerly humediQ GmbH). The arbitration, reported in the latest interim report (Q3 2020/21), is now f...

2021-03-08 16:49 548

Innophys Releases Wearable Work-assisting Robotic Suit "MUSCLE SUIT Every" in France, Spain

TOKYO, March 8, 2021 /PRNewswire/ -- Innophys Co., Ltd. (hereinafter "Innophys") released wearable work-assisting robotic suit "MUSCLE SUIT Every" in France and Spain on March 1. (Photo1: https://kyodonewsprwire.jp/prwfile/release/M106291/202102261529/_prw_PI1fl_zU2T6ytx.jpg

2021-03-08 15:00 451

Dr Ivan Puah notices psychological improvements in patients after undergoing VASER liposuction and fat grafting procedures

SINGAPORE, March 8, 2021 /PRNewswire/ -- Dr. Ivan Puah, an accredited liposuction doctor and Medical Director of Amaris B. Clinic has helped patients address their body fat issues successfully over the past 15 years. This extensive experience provided him with a valuable insight - that the corre...

2021-03-08 09:41 585

Patients Win When Support Is Personalized: New Study From Atlantis Healthcare Shows Treatment Persistence and Adherence Improved by 38%

SYDNEY, March 8, 2021 /PRNewswire/ -- Leading patient outcomes journal Patient Preference and Adherence has published a study that demonstrates significant improvement in treatment behaviors among patients with neovascular age-related macular degeneration (nA...

2021-03-08 08:48 662

Elekta and IBA strengthen partnership to help cancer centers integrate proton therapy

STOCKHOLM, March 5, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that its latest solution for proton therapy,Monaco®* treatment planning for protons, has received 510(k) clearance from the U.S. Food and Drug Administration.Monaco brings robust functionality for proton therapy, featurin...

2021-03-05 15:19 3413

Oxford Immunotec Submits Emergency Use Authorization Request to the FDA and CE Marks T-SPOT®.COVID, a Test for the Detection of a Cell Mediated (T cell) Immune Response to SARS-CoV-2 Infection

OXFORD, United Kingdom and MARLBOROUGH, Mass., March 5, 2021 /PRNewswire/ -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the "Company"), a global, high-growth diagnostics company, announced that today it has released the T-SPOT.COVID test, a CE marked ELISPOT based test intended for qualitative ...

2021-03-05 04:01 3534

Zymo Research Offers Community-Wide SARS-CoV-2 Detection and Variant Tracking with the Environ™ COVID-19 Wastewater Testing Service

IRVINE, Calif., March 4 2021 /PRNewswire/ -- Zymo Research announced today the launch of itsEnviron™ COVID-19 Wastewater Testing Service. This service facilitates daily community-wide monitoring of COVID-19 cases and variants from a single wastewater sample. Daily case estimates and detected SARS...

2021-03-04 14:33 1086

MedAlliance Receives Fourth FDA Breakthrough Device Designation for Sirolimus Drug-Eluting Balloon in Treatment of De Novo Coronary Lesions

NYON, Switzerland, March 4, 2021 /PRNewswire/ -- MedAlliance, the first drug-eluting balloon (DEB) company in the world to receive US Food and Drug Administration (FDA) Breakthrough Device Designation Status for a sirolimus DEB, has now been awarded breakthrough status for SELUTION SLR™, its sust...

2021-03-04 09:00 1047

Medical expert warns thousands could die from HPV programming interrupted by Covid-19

LONDON, March 4, 2021 /PRNewswire/ -- On HPV Awareness Day, the International Papillomavirus Society is urging women to attend delayed cervical screenings and for all interrupted services to re-start as thousands continue to miss out on vital HPV care, with deadly consequences. The IPVS is also c...

2021-03-04 08:01 1000

Remote Pre-Approval Inspection Completed by EMA on WuXi Biologics' MFG4 Facility

WUXI, China, March 3, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, today announced that the European Medicines Agency (EMA) has completed a remote Pre-Approval Inspection (PAI) on its drug substance facility ...

2021-03-03 18:23 479

Seegene's Latest COVID-19 Test Can Simultaneously Target 4 Genes of SARS-CoV-2 and Recognize Multiple Virus Variants

* Seegene's new product filters COVID-19 and variants during primary PCR testing in 1 hr 55 minutes * Seegene's proprietary high multiplex technology enables detection of 10 different targets * S. Korean firm to research additional versions of variant diagnostic tests SEOUL, South Korea,...

2021-03-03 09:20 874

e-condLIFE: Cost of human life and business shut down can be minimized with this new prevention technology

* A smarter preventative way to keep family members safe * Peace of mind for staff and customers that the premises are being disinfected 24 hours KUALA LUMPUR, Malaysia, March 3, 2021 /PRNewswire/ -- Since launching inJune 2020, e-condLIFE has been well received and proven to be effective. Dr...

2021-03-03 09:00 973

AGC Biologics Announces the Expansion of Their Cell and Gene Therapy Facility in Milan, Italy

SEATTLE, March 3, 2021 /PRNewswire/ -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced plans for the expansion of their Cell and Gene Therapy Center of Excellence inMilan, to increase capacities and implement viral vector su...

2021-03-03 08:00 1467

Cipla Gulf Expands Partnership with Alvotech for Commercialization of Biosimilars in Australia and New Zealand

MUMBAI, India, March 2, 2021 /PRNewswire/ -- Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) referred to as "Cipla" today announced that its subsidiary, Cipla Gulf FZ LCC ("Cipla Gulf') is expanding its partnership with Alvotech for the marketing and distribution of four biosimilar medicines inAustra...

2021-03-02 22:05 4901

Ambu Acclaimed by Frost & Sullivan for Its Groundbreaking Single-use Flexible Endoscopes

Ambu's customer-focused innovations and use of advanced technologies help the company address market needs in a wide range of applications SANTA CLARA, Calif., March 2, 2021 /PRNewswire/ -- Based on its recent analysis of the global flexible single-use endoscope market for advanced visualization...

2021-03-02 21:00 738

Cloud-based Enterprise Imaging to Help Expedite Healthcare Providers' Journey of Enabling Better Care

SANTA CLARA, Calif., March 2, 2021 /PRNewswire/ -- Responding to the shift toward value-based care, provider M&A and consolidation, data expansion, and analytics innovations, healthcare providers are accelerating their digital transformation for greater efficiency, automation and access across cl...

2021-03-02 20:03 3955
12345 ... 229